Iris Acquisition Holdings LLC 13D/13G Filings for Liminatus Pharma, Inc. Class A Common Stock (LIMN)

Iris Acquisition Holdings LLC 13D and 13G filings for Liminatus Pharma, Inc. Class A Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-08
4:21 pm
Purchase
2025-04-3013DLiminatus Pharma, Inc. Class A Common Stock
LIMN
Iris Acquisition Holdings LLC6,900,000
26.500%
6,900,000increase
(New Position)
Filing